Location History:
- Frederiksberg C, DK (2020)
- Basel, CH (2022)
Company Filing History:
Years Active: 2020-2022
Title: Carlos Roberto Camozzi: Innovator in Medical Device Formulations
Introduction
Carlos Roberto Camozzi is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medical devices, particularly through his innovative pharmaceutical formulations. With a total of 3 patents to his name, Camozzi continues to push the boundaries of medical technology.
Latest Patents
One of his latest patents is a medical device related to the formulation of Arimoclomol. This invention pertains to a pharmaceutical formulation that allows for the extended release of an active pharmaceutical ingredient, specifically N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, along with its stereoisomers and acid addition salts.
Career Highlights
Throughout his career, Camozzi has worked with several prominent companies in the medical field. Notably, he has been associated with Orphazyme A/S and Syndermix AG, where he has contributed to various innovative projects and advancements in medical technology.
Collaborations
Some of his notable coworkers include Anders Mørkeberg Hinsby and Thomas Kirkegaard Jensen. Their collaborative efforts have further enhanced the development of medical devices and formulations.
Conclusion
Carlos Roberto Camozzi stands out as a key figure in the realm of medical device innovation. His work continues to impact the industry positively, showcasing the importance of creativity and research in advancing healthcare solutions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.